The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-08
DOI
10.1186/s13045-020-00908-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute Myeloid Leukemia: Aging and Epigenetics
- (2020) Polina Zjablovskaja et al. Cancers
- Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
- (2019) Rory M. Shallis et al. BLOOD REVIEWS
- Recent drug approvals for acute myeloid leukemia
- (2019) Catherine Lai et al. Journal of Hematology & Oncology
- Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study
- (2019) Linghui Zhou et al. Journal of Hematology & Oncology
- Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
- (2019) Na Li et al. Journal of Hematology & Oncology
- Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001–2013
- (2018) Xiaolu Song et al. ACTA HAEMATOLOGICA
- New Insights from Studies of Clonal Hematopoiesis
- (2018) Christopher J. Gibson et al. CLINICAL CANCER RESEARCH
- Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population
- (2018) Hui Wei et al. Journal of Hematology & Oncology
- Precision therapy for acute myeloid leukemia
- (2018) Xue Yang et al. Journal of Hematology & Oncology
- Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
- (2018) Jorge Cortes et al. LANCET ONCOLOGY
- Clinical Implications of Clonal Hematopoiesis
- (2018) David P. Steensma MAYO CLINIC PROCEEDINGS
- Acute myeloid leukaemia
- (2018) Nicholas J Short et al. LANCET
- FLT3 inhibitors in acute myeloid leukemia
- (2018) Mei Wu et al. Journal of Hematology & Oncology
- Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study
- (2018) Naval Daver et al. Cancer Discovery
- Novel Agents for Acute Myeloid Leukemia
- (2018) Mario Luppi et al. Cancers
- Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
- (2017) Lars Bullinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute myeloid leukemia in the elderly: therapeutic options and choice
- (2017) Jonathan A. Webster et al. LEUKEMIA & LYMPHOMA
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimation of the Leukemia Risk in Human Populations Exposed to Benzene from Tobacco Smoke Using Epidemiological Data
- (2017) Stacy Fiebelkorn et al. RISK ANALYSIS
- Impact of marital status during diagnosis on cancer-caused specific survival in acute myeloid leukemia patients: a case-control and population-based study
- (2017) Zhuojun Zheng et al. Oncotarget
- Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis
- (2017) Shufen Li et al. Scientific Reports
- New drugs in acute myeloid leukemia: Table 1.
- (2016) T. M. Kadia et al. ANNALS OF ONCOLOGY
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States
- (2016) Luciano J. Costa et al. CANCER
- Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes
- (2016) Jenny N. Poynter et al. Cancer Epidemiology
- Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study
- (2016) Jenny N. Poynter et al. INTERNATIONAL JOURNAL OF CANCER
- ‘Acute myeloid leukemia: a comprehensive review and 2016 update’
- (2016) I De Kouchkovsky et al. Blood Cancer Journal
- An update of current treatments for adult acute myeloid leukemia
- (2015) H. Dombret et al. BLOOD
- How Do Differences in Treatment Impact Racial and Ethnic Disparities in Acute Myeloid Leukemia?
- (2015) M. I. Patel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
- (2015) C Krupka et al. LEUKEMIA
- Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia
- (2015) Quan-shun Wang et al. MOLECULAR THERAPY
- Aging as a driver of leukemogenesis
- (2015) Thomas McKerrell et al. Science Translational Medicine
- The relation between cigarette smoking and risk of acute myeloid leukemia: An updated meta-analysis of epidemiological studies
- (2014) Sophia Fircanis et al. AMERICAN JOURNAL OF HEMATOLOGY
- How I treat the older patient with acute myeloid leukemia
- (2014) G. Ossenkoppele et al. BLOOD
- Chromosome-wide aneuploidy study of cultured circulating myeloid progenitor cells from workers occupationally exposed to formaldehyde
- (2014) Q. Lan et al. CARCINOGENESIS
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
- (2014) Terrence N. Wong et al. NATURE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
- (2013) A. Mardiros et al. BLOOD
- De novo acute myeloid leukemia risk factors
- (2012) Sara S. Strom et al. CANCER
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoking adversely affects survival in acute myeloid leukemia patients
- (2011) Ramya Varadarajan et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of Poverty and Race on Outcomes in Acute Myeloid Leukemia
- (2010) Margaret M. Byrne et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis
- (2010) Abdul Khalade et al. Environmental Health
- Leukemia stem cells
- (2009) Steven W. Lane et al. SEMINARS IN CANCER BIOLOGY
- Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: A case–control study
- (2008) Jonas Björk et al. LEUKEMIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started